The technology sector's semiconductor industry took the reins on Monday and steered both the Nasdaq Composite and S&P 500 Index to fresh all-time highs to kick off the week.
Tech's gains (+1.1%) seemed to come at the expense of overheated cyclical plays, such as energy (-3.4%) and financials (-0.7%), and amid a decline in Treasury rates, with the 10-year yield off 6 basis points to 1.47% (a basis point is one one-hundredth of a percentage point).
"The move in rates is partially in response to some concerns related to the spread of the delta (COVID) variant, which has caused some countries to re-implement restrictions," says Michael Reinking, senior market strategist at the New York Stock Exchange. "This is also hitting oil prices, which briefly traded to a new high earlier before reversing lower." U.S. crude oil futures finished the day off 1.5% to $72.91 per barrel.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Helping lead tech's rally was Nvidia (NVDA, +5.0%), which jumped after fellow semiconductor firm Broadcom (AVGO, +2.3%) backed Nvidia's $40 billion buyout of chip designer Arm. Related names such as Intel (INTC, +2.8%) and Applied Materials (AMAT, +3.5%) followed suit.
The Nasdaq advanced by 1.0% to a record close of 14,500. The S&P 500's 0.2% gain wasn't as robust, but was enough for a new high of 4,290. The Dow Jones Industrial Average retreated, however, declining 0.4% to 34,283.
Other action in the stock market today:
- The small-cap Russell 2000 slipped 0.5% to 2,322.
- Intellia Therapeutics (NTLA) surged 50.2% after the biotech over the weekend reported positive Phase I data for its gene-editing treatment for transthyretin amyloidosis, a genetic liver disorder in which the body builds up abnormal amounts of protein. The treatment, which is being developed with Regeneron Pharmaceuticals (REGN, -1.4%), is the "first-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans," according to an NTLA press release.
- Facebook (FB) jumped 4.2% after a federal judge in the District of Columbia dismissed an antitrust lawsuit brought forth by the Federal Trade Commission (FTC). "The FTC has failed to plead enough facts to plausibly establish a necessary element of all of its Section 2 claims – namely, that Facebook has monopoly power in the market for Personal Social Networking (PSN) Services," read the filing. Today's pop was enough for FB to close above the $1 trillion market-cap level for the first time ever.
- Gold futures edged up 0.2% to settle at $1,780.70 an ounce.
- The CBOE Volatility Index (VIX) rose 0.9% to settle at 15.76.
- Bitcoin prices jumped 6.9% to $34,455.73. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
Maybe You Don't Need to Choose Between Growth and Value
Should investors bank in a continued resurgence of tech and other growthy names for the rest of 2021, or does value still have gas in the tank?
As we discussed today in our free A Step Ahead e-letter, Capital Group, the name behind American Funds, says you don't necessarily need to choose.
"There can be growing companies that are cheap and cheap companies that grow, so value and growth are not in opposition," says Capital Group equity portfolio manager Martin Romo. "We are in a target-rich environment with opportunities to invest in companies that are rapidly growing as well as classic cyclicals."
The "growing companies that are cheap and cheap companies that grow" he speaks of are better known by just four letters: GARP. That stands for "growth at a reasonable price," and even with the major indexes at or near all-time highs, several companies offer just that: the prospects for breakneck growth, but also valuations that represent discounts to their own historical multiples and/or the stock market's current valuation.
If you want your own portfolio to pack this one-two punch, check out these 11 GARP picks.
Disclaimer
Kyle Woodley was long NVDA as of this writing.
-
Elements of a Financial Snapshot for High-Net-Worth IndividualsDiscover how to assess and optimize your finances with the elements of a high-net-worth financial snapshot.
-
Why Digitizing Your Tax Records Can Simplify Your Filing in 2025Tax Records If you can, switching from paper to e-filing your taxes can have many benefits.
-
Stock Market Today: Stocks Dragged Down by Strong DataInvestors weigh the prospect of no more rate cuts in the current cycle.
-
Nvidia CES 2025 Updates: What Investors Need to KnowNvidia stock is the worst Dow Jones stock Tuesday after the AI bellwether made several announcements at CES 2025. Here's what you need to know.
-
Meta Adds Dana White to Its Board, Ends Fact-Checking: What to KnowMeta stock is lower Tuesday after the Facebook parent said it is adding UFC CEO Dana White to its board of directors and ending fact-checking on its platforms.
-
Stock Market Today: Tech Stocks Soar Ahead of CES 2025This week's annual technology event will give updates on AI, EVs and self-driving cars.
-
Investing Moves to Make at the Start of the YearAfter another big year for stocks in 2024, investors may want to diversify in 2025. Here are five portfolio moves to make at the start of the year.
-
Stock Market Today: Stocks End a Strong Year With a WhimperThe S&P 500 notched its first back-to-back 20%+ annual returns since the late 1990s.
-
Stock Market Today: Dow Dives 729 Points but Bounces BackInvestors can still hope for a Santa Claus rally over the next three trading days.
-
Stock Market Today: Dow Sinks 333 Points as Mega Caps SlideThe main indexes sold off at the open and stayed lower through the close, putting the Santa Claus rally at risk.
